Tomaralimab
Tomaralimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Tomaralimab is under investigation in clinical trial NCT01794663 (Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function).
| Trade Name | Tomaralimab |
| Generic | Tomaralimab |
| Tomaralimab Other Names | Tomaralimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Tomaralimab
